PBHNYSEPharmaceutical PreparationsFiscal year ends March 31
Prestige Consumer Healthcare Inc.
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$49.71−0.21 (-0.42%)
Close on Oct 19, 2026
- Market cap
- $2.37B
- P/E (TTM)
- 13.9
- Dividend yield
- –
Prestige Consumer Healthcare statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Prestige Consumer Healthcare | Industry median |
|---|---|---|
| Market Cap | $2.35B | $166.30M |
| Enterprise Value | $4.28B | $88.19M |
| PE Ratio | 13.92 | 20.44 |
| PS Ratio | 2.13 | 3.65 |
| PB Ratio | 1.23 | 2.03 |
| P/FCF Ratio | 10.01 | 17.44 |
| P/OCF Ratio | 9.44 | 12.98 |
Enterprise value
| Measure | Prestige Consumer Healthcare | Industry median |
|---|---|---|
| EV / Sales | 3.88 | 2.51 |
| EV / EBITDA | 13.28 | 14.65 |
| EV / EBIT | 14.76 | 19.00 |
| EV / FCF | 18.20 | 20.86 |
Income (trailing twelve months)
| Measure | Prestige Consumer Healthcare | Industry median |
|---|---|---|
| Revenue | $1.10B | $58.34M |
| Gross Profit | $591.44M | $105.94M |
| Operating Income | $290.17M | -$21.40M |
| Net Income | $172.01M | -$22.46M |
| EBITDA | $322.53M | -$16.91M |
| EPS (Diluted) | $3.57 | -$0.83 |
Margins
| Measure | Prestige Consumer Healthcare | Industry median |
|---|---|---|
| Gross Margin | 53.5% | 52.9% |
| Operating Margin | 26.3% | -44.0% |
| Profit Margin | 15.6% | -40.2% |
| EBITDA Margin | 29.2% | -30.2% |
| FCF Margin | 21.3% | -9.27% |
Returns
| Measure | Prestige Consumer Healthcare | Industry median |
|---|---|---|
| Return on Equity (ROE) | 9.12% | -53.2% |
| Return on Assets (ROA) | 4.30% | -40.9% |
| Return on Invested Capital (ROIC) | 8.24% | -32.4% |
| Return on Capital Employed (ROCE) | 6.57% | -38.1% |
Growth
| Measure | Prestige Consumer Healthcare | Industry median |
|---|---|---|
| Revenue Growth (YoY) | -1.36% | 5.96% |
| Net Income Growth (YoY) | -19.2% | -35.2% |
| EPS Growth (YoY) | -16.2% | -26.2% |
| FCF Growth (YoY) | -12.1% | 2.34% |
| Revenue Growth (3Y CAGR) | -1.17% | 2.25% |
| Revenue Growth (5Y CAGR) | 2.91% | 6.48% |
| EPS Growth (5Y CAGR) | 3.77% | 3.77% |
Balance sheet
| Measure | Prestige Consumer Healthcare | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $89.13M | $61.43M |
| Total Debt | $2.02B | $118.52M |
| Net Cash (Debt) | -$1.93B | $15.35M |
| Net Cash Per Share | -$40.71 | $0.66 |
| Equity (Book Value) | $1.92B | $49.09M |
| Book Value Per Share | $40.46 | $1.37 |
| Tangible Book Value | -$1.98B | $23.52M |
| Working Capital | $343.01M | $76.81M |
Financial position
| Measure | Prestige Consumer Healthcare | Industry median |
|---|---|---|
| Current Ratio | 3.23 | 3.34 |
| Quick Ratio | 1.80 | 2.44 |
| Debt / Equity | 1.05 | 0.52 |
| Debt / EBITDA | 6.26 | 3.44 |
| Debt / FCF | 8.57 | 4.89 |
| Net Debt / EBITDA | 5.98 | 2.36 |
Cash flow (trailing twelve months)
| Measure | Prestige Consumer Healthcare | Industry median |
|---|---|---|
| Operating Cash Flow | $249.40M | -$12.35M |
| Capital Expenditures | -$14.04M | -$1.08M |
| Free Cash Flow | $235.36M | -$20.22M |
| FCF Per Share | $4.97 | -$0.42 |
Efficiency
| Measure | Prestige Consumer Healthcare | Industry median |
|---|---|---|
| Asset Turnover | 0.28 | 0.39 |
| Inventory Turnover | 2.99 | 2.70 |
| Revenue Per Employee | $1.24M | $404.87K |
| Profits Per Employee | $193.27K | -$703.34K |
| Employee Count | 890 | 74 |
Dividends and yields
| Measure | Prestige Consumer Healthcare | Industry median |
|---|---|---|
| Earnings Yield | 7.30% | -23.3% |
| FCF Yield | 9.99% | -8.72% |
| Buyback Yield | 5.16% | -0.59% |
| Shareholder Yield | 5.16% | 0.00% |
Shares
| Measure | Prestige Consumer Healthcare | Industry median |
|---|---|---|
| Shares Outstanding | 47,374,500 | 58,127,000 |
| Shares Change (YoY) | -3.62% | 10.9% |
| Float | 46,692,700 | 49,136,700 |
| Shares Held by Insiders | 1.44% | 11.6% |
| Shares Held by Institutions | 113.5% | 59.4% |
Taxes
| Measure | Prestige Consumer Healthcare | Industry median |
|---|---|---|
| Income Tax | $62.25M | $79.87K |
Scores
| Measure | Prestige Consumer Healthcare | Industry median |
|---|---|---|
| Graham Number | $57.01 | $18.73 |
| Graham Upside | 14.7% | -45.1% |
| Altman Z-Score | 1.62 | -0.22 |
| Piotroski F-Score | 4 | 4 |
Calculated by StockData from Prestige Consumer Healthcare's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.